Latest Insider Transactions at Walgreens Boots Alliance, Inc. (WBA)
This section provides a real-time view of insider transactions for Walgreens Boots Alliance, Inc. (WBA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Walgreens Boots Alliance, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Walgreens Boots Alliance, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2023
|
Timothy C Wentworth Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
562,324
+50.0%
|
-
|
|
Nov 01
2023
|
Neal J. Sample EVP, Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
193,767
+34.74%
|
-
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,091
-1.06%
|
$85,911
$21.08 P/Share
|
|
Nov 01
2023
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
118,557
+38.06%
|
-
|
|
Nov 01
2023
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,430
-1.36%
|
$51,030
$21.08 P/Share
|
|
Nov 01
2023
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
35,145
+36.92%
|
-
|
|
Nov 01
2023
|
Danielle Gray EVP and Global CLO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,758
-1.11%
|
$99,918
$21.08 P/Share
|
|
Nov 01
2023
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
134,021
+38.39%
|
-
|
|
Nov 01
2023
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
839
-0.99%
|
$17,619
$21.08 P/Share
|
|
Nov 01
2023
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
16,401
+36.44%
|
-
|
|
Nov 01
2023
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
5,725
-2.06%
|
$120,225
$21.08 P/Share
|
|
Nov 01
2023
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
217,901
+43.95%
|
-
|
|
Nov 01
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,378
-0.6%
|
$28,938
$21.08 P/Share
|
|
Nov 01
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,860
+38.05%
|
-
|
|
Nov 01
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,458
-0.99%
|
$72,618
$21.08 P/Share
|
|
Nov 01
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
84,349
+41.81%
|
-
|
|
Nov 01
2023
|
Tracey D Brown EVP, Pres., Walgreens Retail |
SELL
Payment of exercise price or tax liability
|
Direct |
4,037
-1.3%
|
$84,777
$21.08 P/Share
|
|
Nov 01
2023
|
Tracey D Brown EVP, Pres., Walgreens Retail |
BUY
Grant, award, or other acquisition
|
Direct |
117,151
+42.84%
|
-
|
|
Nov 01
2023
|
Thomas E Polen Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,696
+50.0%
|
-
|
|
Nov 01
2023
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,694
+38.93%
|
-
|
|
Nov 01
2023
|
Bryan C Hanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,694
+50.0%
|
-
|
|
Nov 01
2023
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
6,235
-0.99%
|
$130,935
$21.08 P/Share
|
|
Nov 01
2023
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
257,732
+29.07%
|
-
|
|
Oct 25
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-3.88%
|
$24,969
$21.37 P/Share
|
|
Oct 25
2023
|
Richard P. Gates SVP, Chief Pharmacy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,057
+11.69%
|
-
|
|
Oct 25
2023
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-4.56%
|
$24,969
$21.37 P/Share
|
|
Oct 25
2023
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
4,057
+13.46%
|
-
|
|
Oct 25
2023
|
Todd Heckman SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
849
-6.5%
|
$17,829
$21.37 P/Share
|
|
Oct 25
2023
|
Todd Heckman SVP, Global Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
2,898
+18.16%
|
-
|
|
Oct 25
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,933
-5.53%
|
$40,593
$21.37 P/Share
|
|
Oct 25
2023
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,796
+14.22%
|
-
|
|
Oct 25
2023
|
Ornella Barra Chief Operating Officer, Int'l |
SELL
Payment of exercise price or tax liability
|
Direct |
7,089
-1.87%
|
$148,869
$21.37 P/Share
|
|
Oct 25
2023
|
Ornella Barra Chief Operating Officer, Int'l |
BUY
Grant, award, or other acquisition
|
Direct |
52,167
+12.12%
|
-
|
|
Oct 25
2023
|
Stefano Pessina Executive Chairman of Board |
BUY
Grant, award, or other acquisition
|
Direct |
207,039
+16.38%
|
-
|
|
Jun 30
2023
|
John Patrick Driscoll EVP, Pres. U.S. Healthcare |
BUY
Open market or private purchase
|
Direct |
5,172
+8.05%
|
$144,816
$28.42 P/Share
|
|
Jun 01
2023
|
Danielle Gray EVP and Global CLO |
BUY
Grant, award, or other acquisition
|
Direct |
32,982
+29.28%
|
-
|
|
Jun 01
2023
|
Holly May EVP, Global Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
32,982
+31.1%
|
-
|
|
May 01
2023
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,020
-2.19%
|
$210,700
$35.25 P/Share
|
|
Apr 18
2023
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
18,833
+6.42%
|
-
|
|
Mar 29
2023
|
Rosalind G Brewer CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+2.63%
|
$330,000
$33.95 P/Share
|
|
Mar 15
2023
|
Rosalind G Brewer CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,301
-6.57%
|
$834,933
$33.29 P/Share
|
|
Nov 18
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,303
-26.96%
|
$412,120
$40.19 P/Share
|
|
Nov 18
2022
|
Kevin M. Ban EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,303
+21.23%
|
$350,302
$34.04 P/Share
|
|
Nov 17
2022
|
Nancy M Schlichting Director |
SELL
Open market or private sale
|
Direct |
16,570
-75.03%
|
$646,230
$39.89 P/Share
|
|
Nov 01
2022
|
James Kehoe EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,678
-1.5%
|
$420,408
$36.26 P/Share
|
|
Nov 01
2022
|
James Kehoe EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
60,818
+18.79%
|
-
|
|
Nov 01
2022
|
Rosalind G Brewer CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,326
-2.41%
|
$335,736
$36.26 P/Share
|
|
Nov 01
2022
|
Rosalind G Brewer CEO |
BUY
Grant, award, or other acquisition
|
Direct |
155,280
+28.67%
|
-
|
|
Nov 01
2022
|
Manmohan Mahajan EVP and Global CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
815
-1.25%
|
$29,340
$36.26 P/Share
|
|
Nov 01
2022
|
Manmohan Mahajan EVP and Global CFO |
BUY
Grant, award, or other acquisition
|
Direct |
9,705
+30.56%
|
-
|